A detailed history of Uncommon Cents Investing LLC transactions in Biogen Inc. stock. As of the latest transaction made, Uncommon Cents Investing LLC holds 2,749 shares of BIIB stock, worth $460,594. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,749
Previous 2,739 0.37%
Holding current value
$460,594
Previous $343,000 12.24%
% of portfolio
0.1%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$122.68 - $148.84 $1,226 - $1,488
10 Added 0.37%
2,749 $385,000
Q2 2025

Jul 16, 2025

SELL
$113.38 - $135.49 $81,180 - $97,010
-716 Reduced 20.72%
2,739 $343,000
Q1 2025

Apr 22, 2025

SELL
$133.43 - $153.27 $1,334 - $1,532
-10 Reduced 0.29%
3,455 $472,000
Q4 2024

Jan 16, 2025

SELL
$146.47 - $191.55 $10,985 - $14,366
-75 Reduced 2.12%
3,465 $529,000
Q3 2024

Oct 17, 2024

SELL
$189.07 - $236.8 $251,463 - $314,944
-1,330 Reduced 27.31%
3,540 $686,000
Q2 2024

Jul 17, 2024

BUY
$190.52 - $236.72 $1,905 - $2,367
10 Added 0.21%
4,870 $1.13 Million
Q1 2024

Apr 19, 2024

BUY
$212.02 - $267.71 $74,207 - $93,698
350 Added 7.76%
4,860 $1.05 Million
Q4 2023

Jan 18, 2024

BUY
$222.59 - $267.94 $176,959 - $213,012
795 Added 21.4%
4,510 $1.17 Million
Q3 2023

Oct 19, 2023

BUY
$253.3 - $285.89 $231,769 - $261,589
915 Added 32.68%
3,715 $954,000
Q2 2023

Jul 20, 2023

BUY
$275.25 - $318.06 $401,865 - $464,367
1,460 Added 108.96%
2,800 $797,000
Q1 2023

Apr 14, 2023

BUY
$256.56 - $292.34 $101,341 - $115,474
395 Added 41.8%
1,340 $372,000
Q4 2022

Jan 13, 2023

BUY
$252.44 - $306.72 $238,555 - $289,850
945 New
945 $0

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Uncommon Cents Investing LLC Portfolio

Follow Uncommon Cents Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uncommon Cents Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Uncommon Cents Investing LLC with notifications on news.